← FTC press releases
FTC Final Order with Baxter International and Claris Lifesciences Preserves U.S. Competition for the Injectable Drugs Intravenous Fluconazole and Intravenous Milrinone
other
· 2017-08-01
Source
Authoritative
FTC press release
Machine
JSON-LD
·
Markdown